期刊文献+

透析法和稀释法复性重组人Cu,Zn-SOD包含体 被引量:1

Renaturation of Recombinant Human Cu,Zn-Superoxide Dismutase by Dilution and Dialysis
下载PDF
导出
摘要 以稀释法和透析法对在E.coli中以包含体形式表达的重组人超氧化物歧化酶(rhSOD)进行复性.以8 mol/L尿素溶解分离纯化的包含体(纯度达80%以上),对其稀释或透析至尿素终浓度为1.0 mol/L后,在稀释样品中补加终浓度50μmoL/L的Cu2+和5.0μmoL/L的Zn2+,在透析样品中补加终浓度5.0μmoL/L的Cu2+和0.5μmoL/L的Zn2+,分别获得了比活3 300 u/mg和4 300 u/mg的复性rhSOD.该复性样品经铜螯合亲和层析柱纯化可获得更高比活性的rhSOD. The recombinant human Cu, Zn-superoxide dismutase (rhCu, Zn-SOD) expressed in E. coli in the form of inclusion body was renatured by dilution and dialysis. After separated and purified inclusion body (over 80% purity) was redissolved in 8 mol/L urea and centrifuged, it was diluted or dialyzed into 1.0 mol/L urea. The diluted sample was supplemented with 50μmoL/L Cu2^2+ and 5.0 μmoL/L Zn^2+ and the dialyzed sample was supplemented with 5.0 μmoL/L Cu2^+ and 0.5μ moL/L Zn^2+. The specific activity of the renatured rhSOD was 3 300 u/mg and 4 300 u/mg respectively. The renatured samples can be further purified by metals-chelaing affinity chromatography(MCAC).
出处 《河北大学学报(自然科学版)》 CAS 北大核心 2006年第4期411-414,419,共5页 Journal of Hebei University(Natural Science Edition)
关键词 重组人Cu Zn—SOD 复性 包含体 recombinant human Cu, Zn-superoxide dismutase renaturation inclusion body
分类号 O816 [理学]
  • 相关文献

参考文献6

二级参考文献18

  • 1静天玉,赵晓瑜.用终止剂改进超氧化物歧化酶邻苯三酚测活法[J].生物化学与生物物理进展,1995,22(1):84-86. 被引量:170
  • 2袁勤生,金新根.超氧化物歧化酶的研究进展[J].中国药学杂志,1989,24(7):395-397. 被引量:34
  • 3谢卫华 姚菊芳 等.-[J].医药工业,1988,19(5):217-219.
  • 4方允中 刘智峰 等.抗牛CuZn-SOD抗血清与恶性肿瘤病人血中CuZn-SOD的抗原抗体反应[J].中华医学杂志,1987,67:351-352.
  • 5周潮 方允中 等.自由基生命科学进展,第4集[M].北京:原子能出版社,1996.80.
  • 6程君毅,生化药物杂志,1988年,2期,53页
  • 7丁克祥,老年学杂志,1978年,7卷,2期,42页
  • 8周潮,自由基生命科学进展.4,1996年,80页
  • 9方允中,自由基生命科学进展.3,1993年,1页
  • 10谢卫华,医药工业杂志,1988年,19卷,5期,217页

共引文献204

同被引文献5

  • 1郭井利,彭永刚,刘鹏,孙文毅,刘冰.重组蛋白在大肠杆菌中包涵体蛋白的表达及其复性[J].畜牧兽医科技信息,2005,21(8):66-68. 被引量:2
  • 2FRANCIS G L,et al. Novel Recombinant Fusion Protein Analogues of Insulin-like Growth Factor(IGF- I )Indicate the Relative Importance of IGF-Binding Protein and Receptor Binding for Enhanced Biological POTENCY [J]. J Mol Endocrinol, 1992,8:213-223.
  • 3LEANNE G,LAAJOKI,GEOFFREY L,FRANCIS ,JOHN C WAOOACE ,et al. Solution Structure and Backbone Dynamics of Long-[Arg3]insulin-like Growth Factor-I[J].The Journal of Biological Chemistry,2000,275(14) :10009-10015.
  • 4MICHAEL D. HARVEY ,PETER R. BANKS. Site-specific Fluorescent Derivatization and Liquid Chromatographic-3 Mass Spectrometric Characterization of Long R IGF-I Forbioanalytical Applications[J]. Journal of Chromatography B, 2003,793:115-125.
  • 5CHAN S J,CAO Q P, STEINER F D. Evolution of the insulin superfamily., cloning of a hybrid insulin/insulin-like growth factor cDNA from amphioxus[J]. Proc Natl Acad Sci U S A, 1990,87: 9319-9323.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部